Safety of Extracellular Vesicles for Burn Wounds
NCT05078385
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
1
Enrollment
INDUSTRY
Sponsor class
Conditions
Burns
Interventions
DRUG:
AGLE-102
Sponsor
Aegle Therapeutics
Collaborators
[object Object]